{"id":"W4417004073","doi":"10.1182/blood-2025-1801","title":"Phase 2 bellwave-003 cohort f: Updated clinical outcomes of nemtabrutinib in participants with relapsed or refractory marginal zone lymphoma","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Ibrutinib; Chronic lymphocytic leukemia; Mantle cell lymphoma; Cohort; Bruton's tyrosine kinase; Idelalisib; Refractory (planetary science); Phases of clinical research; Bendamustine; Follicular lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005229687,0.0008299588,0.0009327226,0.0003970946,0.0005895874,0.001168168,0.001080842,0.001001988,0.005390815],"category_scores_gemma":[0.002030582,0.0002800433,0.001234088,0.000464872,0.0003450686,0.00101786,0.0007880113,0.001781442,0.001785485],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001460145,"about_ca_system_score_gemma":0.001540478,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002022915,"about_ca_topic_score_gemma":0.005306406,"domain_scores_codex":[0.9992344,0.0002696847,0.00003912931,0.0001488982,0.0001748054,0.0001331551],"domain_scores_gemma":[0.9979805,0.0002359402,0.0005658767,0.0001545098,0.0004469802,0.0006160951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2752357,0.01212311,0.2985522,0.001882859,0.004820338,0.0005954253,0.0005173794,0.002445642,0.03177493,0.0009169173,0.1004399,0.2706955],"study_design_scores_gemma":[0.1104762,0.1385821,0.6468535,0.0006783515,0.004705034,0.002044202,0.0004140938,0.004299093,0.008911054,0.001595512,0.08124205,0.0001986919],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9168003,0.006380529,0.00236975,0.002102995,0.0002225693,0.004434283,0.05512514,0.0003630897,0.01220137],"genre_scores_gemma":[0.8898483,0.002461043,0.004566882,0.004191626,0.0003017624,0.005171053,0.08683674,0.0001312012,0.006491397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005390815,"threshold_uncertainty_score":0.02765751,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03601716492113827,"score_gpt":0.3636572974253188,"score_spread":0.3276401325041806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}